HB
Hardik Bhadabhai Soliya
About Hardik Bhadabhai Soliya
Data last updated:
Hardik Bhadabhai Soliya is a Director at Augxen Pharma Private Limited (since 2021). The companies operate in Pharma and Chemicals and Materials. Augxen Pharma Private Limited reported revenue of ₹27.52 Cr (FY 2025). Earlier, Hardik Bhadabhai Soliya was a Designated Partner at Alkalinechem Llp (2020–2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 22 Jul 2021 | 2021 | ₹27.52 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 24 Dec 2020 | 2020 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Hardik Bhadabhai Soliya
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gajera Manishaben Vijaybhai | 09250068 | Augxen Pharma Private Limited | Director |
| Ranjanaben Patil | 09250066 | Augxen Pharma Private Limited | Director |
| Savanbhai Devchandbhai Tibadiya | 09009044 | Augxen Pharma Private Limited | Director |
| Vandanaben Maheshbhai Matholiya | 09250067 | Augxen Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hardik Bhadabhai Soliya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hardik Bhadabhai Soliya
Hardik Bhadabhai Soliya currently holds 1 directorship: Augxen Pharma Private Limited (Director, since 22 Jul 2021, revenue ₹27.52 Cr (FY 2025)).
Hardik Bhadabhai Soliya was first appointed on 24 Dec 2020 as Designated Partner at Alkalinechem Llp. The most recent appointment on record is 22 Jul 2021 at Augxen Pharma Private Limited.
Hardik Bhadabhai Soliya held 1 earlier board appointment: Alkalinechem Llp (Designated Partner, 24 Dec 2020 to 12 Nov 2024).
The current boards of Hardik Bhadabhai Soliya's companies include Gajera Manishaben Vijaybhai (Augxen Pharma Private Limited), Ranjanaben Patil (Augxen Pharma Private Limited), Savanbhai Devchandbhai Tibadiya (Augxen Pharma Private Limited), Vandanaben Maheshbhai Matholiya (Augxen Pharma Private Limited).